21
Views
6
CrossRef citations to date
0
Altmetric
Meeting Report

American Association for Cancer Research 1998: promises and prospects for the next century

Pages 1015-1021 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Chia-Yu Huang & Laura Rokosz. (2004) Farnesyltransferase inhibitors: recent advances. Expert Opinion on Therapeutic Patents 14:2, pages 175-186.
Read now
Julia E Head & Stephen RD Johnston. (2003) Protein farnesyltransferase inhibitors. Expert Opinion on Emerging Drugs 8:1, pages 163-178.
Read now
François Lavelle. (1999) American Association for Cancer Research 1999: 10-14 April, Philadelphia, Pennsylvania. Expert Opinion on Investigational Drugs 8:6, pages 903-909.
Read now

Articles from other publishers (3)

Bridget T Hill, Dominique Perrin & Anna Kruczynski. (2000) Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited. Critical Reviews in Oncology/Hematology 33:1, pages 7-23.
Crossref
Dominique Perrin & Bridget T. Hill. 2000. New Approaches to Drug Development. New Approaches to Drug Development 153 179 .
James M Hamby & H.D.Hollis Showalter. (1999) Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors. Pharmacology & Therapeutics 82:2-3, pages 169-193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.